Literature DB >> 31410073

The effect of a mesenchymal stem cell conditioned medium fraction on morphological characteristics of hepatocytes in acetaminophen-induced acute liver failure: a preliminary study.

Andrey Temnov1,2, Konstantin Rogov3,4, Vitaliy Zhalimov1, Popov Igor2, Stanislav Pekov2, Augustinus Bader5, Alla Sklifas1, Shibashish Giri5,6.   

Abstract

Background: In our studies, it was shown that the effectiveness of the conditioned medium obtained by cultivating mesenchymal stem cells depends on the microenvironment conditions used to cultivate the cells. It was demonstrated that the conditioned medium obtained by culturing cells with low oxygen content (10%) has a much more pronounced protective effect.
Methods: Protein compositions obtained from MSCs cultured under hypoxic (10% O2 hc-MSC) and normal (21% O2 nc-MSC) conditions were used to treat acute liver failure (ALF) induced in mice by acetaminophen injection. Thus, we obtained fractions normalized by volume, which predominantly contained proteins with masses > 50, 50-30, 30-10, and 10-3 kDa.
Results: The data from biochemical studies have shown that only fractions from 10 to 30 kDa (hcMSC and ncMSC) significantly reduced the level of liver enzymes in the beginning of the acute period after acetaminophen administration. Mass spectrometry analysis of the proteins contained in the isolated fractions showed a sharp increase in the protein levels in the 10-30 kDa hcMSC fraction as compared with that in 10-30 kDa ncMSCs. The composition obtained from MSCs cultured at lower O2 level (fraction 10-30 kDa hcMSC) was shown to be more potent than the composition prepared from normoxic cells.
Conclusion: The results have shown that a composition obtained by culturing the cells under a reduced content of O2 (10%), significantly improves the biochemical parameters, and histological arrester reduces the degree of inflammation and stimulates regenerative processes in liver, compared to both the control group and group treated with the composition that was obtained by culturing the cells under normal oxygen content.

Entities:  

Keywords:  acute hepatic failure; condition media; galectin-1; mass spectrometry; stem cells

Year:  2019        PMID: 31410073      PMCID: PMC6650605          DOI: 10.2147/HMER.S196354

Source DB:  PubMed          Journal:  Hepat Med        ISSN: 1179-1535


Introduction

Acute liver failure (ALF) is a condition where hepatocyte death occurs within days or weeks without cirrhosis signs. The death can be caused by numerous agents, including viruses, toxins, and drugs. In the United States, approximately 2,000 people are diagnosed with ALF every year, and almost 60% of the cases are caused by acetaminophen (APAP) or idiosyncratic drug reactions caused by drugs.1 In general, APAP-induced injury significantly exceeds idiosyncratic drug-induced liver injury, with their approximate ratio being 4:1. Most APAP-associated ALF cases have signs of suicide; however, as early as the 1980s, there were reported cases of the ALF development associated with therapeutic drug administration or alcohol-tylenol syndrome.2,3 N-acetylcysteine (NAC) is the best treatment for paracetamol poisoning. Since the 1970s, NAC therapy has been the best therapeutic option for treating patients with APAP-induced ALF. However, various adverse reactions to NAC, with their severity ranging from minor to fatal, have been reported in the clinic.4 In addition, the therapeutic window for the introduction of NAC is rather narrow, while some patients already have signs of ALF. Finally, NAC binds toxic NAPQI, but its effectiveness is drastically reduced in the late stages of the pathological process. It is also known that NAC is much less effective in APAP-treated mice.5 Consequently, the development of new drugs designed to suppress the progression of APAP-induced hepatitis is of great importance and would be highly desirable. One of the effective ways of treating ALF developed due to APAP administration is transplantation of mesenchymal stem cells.6,7 A number of studies have demonstrated that transplantation causes an anti-inflammatory, anti-apoptotic, and proliferative effect on mice.8,9 However, some authors believe that the clinical effect caused by the introduction of stem cells is primarily associated with paracrine factors released by cells into culture medium. In this case, introduction of conditioned medium derived from stem cells exerts an effect that is only slightly inferior to that of MSC introduction.10 In our previous studies, we demonstrated that the effectiveness of conditioned medium obtained during cultivation of mesenchymal stem cells depended on the microenvironment conditions used for cultivation of the cells.11 For example, conditioned medium obtained during cultivation of cells under low oxygen content (10%) condition was demonstrated to have a significantly more pronounced protective effect.9 The purpose of this study was to isolate a molecular fraction of the conditioned medium, which possessed the maximum protective effect in APAP-induced liver failure, and to characterize changes, using mass spectrometry, in the qualitative and quantitative composition of proteins, depending on cultivation conditions.

Materials and methods

Preparation of bone marrow stem cells

To isolate MSCs, the bone marrow was harvested from the femur of CD1 mice under general anesthesia. The mononuclear fraction of bone marrow cells was isolated on a density gradient using a standard Lympholyte-H solution (Cedarlane, Canada). After preparation, the suspension of mononuclear cells was seeded on Petri dishes and cultured in DMEM medium with addition of 10% fetal calf serum (Gibco). The produced cells were subjected to osteogenic, chondrogenic, and adipogenic differentiation according to the standard technique to confirm the fact that they possessed the MSC properties.12 Osteogenic differentiation (with addition of 10% fetal calf serum, 100 μM dexamethasone, 0.1 mM ascorbic acid, and 10 nM β-glycerophosphate) was confirmed by the presence of alkaline phosphatase in cell culture using standard reagents (Sigma-Aldrich, USA). Chondrogenic differentiation (with addition of 10% fetal calf serum, 100 μM dexamethasone, and 0.1 μg/mL TGF-β) was confirmed by alcian blue staining. Adipogenic differentiation (with addition of 10% fetal calf serum, 10 μM dexamethasone, 10 μg/mL insulin, and 100 μg/mL IBMX) was confirmed by Oil Red-O staining.

MSC cultivation

A cell monolayer was cultivated under normoxia (21% O2 and 5% CO2 ncMSC) and hypoxia (10% O2 and 5% CO2 hcMSC) conditions. We could not see any differences between the cells; the stabs were cultivated under conditions of normoxia (CD44 98.2%, CD90 97.6%, CD31 1.0%, and CD45 0.6%) and hypoxia (CD44 97.0%, CD90 97.3%, CD31 1.1%, and CD45 0.8%).

CMSC preparation

After preparing the cell monolayer, culture medium was completely refreshed, and, after 3 days, conditioned culture medium was combined with the MSC lysate (1:1). The conditioned medium derived from MSCs cultured under normoxia conditions was designated as ncMSC, and the conditioned medium obtained from MSCs cultured under hypoxia conditions was designated as hcMSC.

Fraction preparation

Ultrafiltration was used to separate conditioned medium. 10 mL of studied conditioned medium was placed in an Amicon Ultra-15 50,000 NMWL filter device (Millipore, Ireland) and centrifuged using a swinging-bucket rotor at +4ºC for 25 mins. The upper fraction was washed three times with 10 mL of 1X PBS (Amresco, USA), transferred to a new tube, and adjusted to a volume of 10 mL with 1X PBS. The filtrate obtained during the first filtration was transferred to a 30,000 NMWL concentrator. The filtration procedure was carried out as described above, except that the upper fraction was diluted to the filtrate volume initially introduced into the concentrator. Thus, we obtained fractions normalized by volume, which contained predominantly proteins with masses >50, 50–30, 30–10, and 10–3 kDa.

Mass spectrometry

The protein solution pH was adjusted to 8.0 by adding 1M Tris-Cl, followed by addition of 5% acetonitrile to facilitate further hydrolysis. 50 μL of the protein solution was mixed with 5 μL of 50 mM DTT and incubated at 65ºC for 5 mins, followed by addition of 5 μL of 100 mM IAA and incubation at 30ºC in a dark place for 30 mins. Then, 5 μL of 1 μg/μL sequencing grade trypsin (Promega) was added and incubated at 37ºC overnight. The reaction was stopped by adding 5 μL of 0.5% acetic acid. The reaction mixture was centrifuged at 12,500 g for 10 mins, and the supernatant was transferred to a new tube and stored at –20ºC until further analysis. Peptide mixtures were analyzed on a nano-HPLC Agilent 1100 system (Agilent Technologies, Santa Clara, CA, USA) combined with a 7T LTQ-FT Ultra mass spectrometer (Thermo Electron, Bremen, Germany) equipped with a nanospray ion source (positive mode). Peptides were separated on a homemade capillary column (Fused-silica PicoTip®; emitter id, 75 μm; length, 12 cm; nominal tip id, 15 μm) packed with Reprosil-Pur Basic C18, 3 μm, 100A (Dr Maisch HPLC GmbH, Ammerbuch-Entringen, Germany). The separation was carried out using a 120-min gradient (H2O/ACN containing 0.1% formic acid) from 3% to 90% of ACN at a flow rate of 300 nL/min. MS and MS/MS data were acquired in a data-dependent mode using the Xcalibur (Thermo Finnigan, San Jose, USA) software. MS data were analyzed using the MaxQuant program against the SwissProt database with an initial precursor mass error of 10 ppm. The minimum peptide length for identification was set to seven amino acids; the “match between runs” option was activated, and the cutoff false discovery rate was set to 0.01. Proteins with more than two peptides and with at least one unique peptide were considered as identified. For protein quantification, label-free analysis was used.

Simulation of ALF

Male mice of the BaLb line weighing 22–24 g were divided into two groups (the control and experimental ones). APAP was administered intraperitoneally at a dose of 270 mg/kg to animals of all groups. After 15 mins, animals in the control group (No. 1, n=15) were intraperitoneally injected with 1 mL of intact culture medium (DMEM supplemented with 10% fetal calf serum without culturing any cells), whereas all animals in the experimental group (group No. 2=15 and No. 3 n=15) received 1 mL of ncMSC or hcMSC compositions (0.5 mL condition media +0.5 mL lysate MSC, protein concentration, 10 mg/mL).

Histology

Material for histological examination was collected 4 hrs after APAP administration. For morphological assessment of changes, the liver of mice was fixed in 10% neutral buffered formalin, and 4–5 µm thick serial paraffin sections were prepared. Dystrophic and necrotic changes in the liver were scored based on analysis of 10 fields of view using a semi-quantitative blind method.13 The following scale was used: 0 – no changes; 0.5 – dystrophic changes in <1/3 of hepatocytes; 1 – dystrophic changes in more than 1/3 of hepatocytes; 2 – dystrophic changes in more than 2/3 of hepatocytes; 3 – dystrophic changes in 100% of hepatocytes; 4 – the sample contains a combination of dystrophy with single focal necroses; and 5 – extensive focal necrosis. For scored assessment, six animals in each group were examined.

Biochemical study

The levels of liver enzymes GPT and GOT were measured in intact animals before administration of APAP. The effect of the abovementioned composition was evaluated based on changes in the serum levels of ALS and GOT in animals 4 hrs after administration of APAP. The serum levels of GOT and GPT were determined using the kinetic method on an Olympus AU2700 biochemical analyzer (Beckman Coulter, USA).

Statistical analysis

Statistical analysis was performed using the Statistica 6.0 software. The Mann–Whitney U-test was used for non-parametric data. Differences were considered statistically significant at p<0.05.

Ethical considerations

Ethical clearance for the study was obtained from the Institute of Cell Biophysics of the Russian Academy of Sciences prior to study initiation. The study was conducted in compliance with the principles of the Declaration of Helsinki. In addition to the approval from the Institute of Cell Biophysics of the Russian Academy of Sciences, the maintenance and ethical treatment of laboratory animals was done in accordance with Guidelines of the European Convention for the Protection of Vertebrate animals used for experiments and Guidelines for working with laboratory animals in ICB RAS, Order N39 from December 30, 2018.

Results

The biochemical study data demonstrated that only 10–30 kDa fractions (hcMSC and ncMSC) significantly reduced the level of hepatic enzymes in the acute period onset after administration of APAP (Figure 1). Other fractions did not significantly reduce the level of cytolytic enzymes.
Figure 1

Activities of liver enzymes GPT in animals treated with hcMSC or ncMSC 4 hrs after administration of acetaminophen.Abbreviations: hc-MSC, MSCs cultured under hypoxic (10% O2 hc-MSC) condition; nc-MSC MSCs cultured under normal (21% O2 nc-MSC) condition.

Activities of liver enzymes GPT in animals treated with hcMSC or ncMSC 4 hrs after administration of acetaminophen.Abbreviations: hc-MSC, MSCs cultured under hypoxic (10% O2 hc-MSC) condition; nc-MSC MSCs cultured under normal (21% O2 nc-MSC) condition. For example, the following enzyme levels were detected in the control group at 4 hrs: GPT (blue curve) – 3,322.0±213.0 U/L, GOT (red curve) 1,285.5±98.2 U/L, which exceeded the intact control levels 29.8- and 12.2-fold, respectively. In a group of animals receiving the 10–30 kDa hcMSC fraction, the GPT and GOT levels were 3.4- and 2-fold higher, respectively, as compared to those in the intact control. In animals receiving the 10–30 kDa ncMSC fraction, a significantly greater increase in the enzyme levels was observed compared to hcMSC-treated animals, which exceeded the intact control levels 12.1- (GPT) and 3.1-fold (GOT), respectively (Figure 2).
Figure 2

Activities of liver enzymes GPT and GOT in the control group and in animals treated with hcMSC (10–30 kDa) or ncMSC (10–30 kDa) after the administration of acetaminophen.Notes: *p<0.05 Compared with intact control. @p<0.05 Compared with 24 h. #p<0.05 Compared with Control group.Abbreviations: hc-MSC, MSCs cultured under hypoxic (10% O2 hc-MSC) condition; nc-MSC MSCs cultured under normal (21% O2 nc-MSC) condition.

Activities of liver enzymes GPT and GOT in the control group and in animals treated with hcMSC (10–30 kDa) or ncMSC (10–30 kDa) after the administration of acetaminophen.Notes: *p<0.05 Compared with intact control. @p<0.05 Compared with 24 h. #p<0.05 Compared with Control group.Abbreviations: hc-MSC, MSCs cultured under hypoxic (10% O2 hc-MSC) condition; nc-MSC MSCs cultured under normal (21% O2 nc-MSC) condition. A mass spectrometry analysis of the proteins contained in isolated fractions showed a sharp increase in levels of the following proteins in the 10–30 kDa hcMSC fraction (Table 1) as compared to ncMSC: elongation factor 1-delta (21.5 kDa), platelet-activating factor acetylhydrolase (22.1 kDa), and nucleophosmin (30 kDa). In addition, the concentrations of 10 proteins increased: for tropomyosin (28.3 kDa), it changed 13.1-fold; for thioredoxin (Trx) (11.7 kDa), 1.7-fold; for myotrophin (12.9 kDa), 3.6-fold; for superoxide dismutase [Cu-Zn] (15.9 kDa), 3.1-fold, for macrophage migration inhibitory factor (12.5 kDa), 1.4-fold; for galectin-1 (14.9 kDa), 1.3-fold; for nucleoside diphosphate kinase (17.2 kDa), 1.8-fold; for peptidyl-prolyl cis-trans isomerase (18.0 kDa), 1.5-fold, for Rho GDP-dissociation inhibitor 1 (23.4 kDa), 1.4-fold and for myosin light polypeptide 6 (17.0 kDa), 1.2-fold.
Table 1

Results of the analysis of ncMSC and hcMSC (mass spectrometry)

ProteinMol. weight [kDa]10–30 hcMSC10–30 ncMSChcMSC/ncMSC
Intensity,x103Intensity,x103
Elongation factor 1-delta21,4789520High
Platelet-activating factor acetylhydrolase22,05610710High
Nucleophosmin29,52422820High
Tropomyosin28,3439657413.1
Thioredoxin11,6754,2192,4811.7
Myotrophin12,8612,0475683.6
Superoxide dismutase [Cu-Zn]15,9421,6135153.1
Macrophage migration inhibitory factor12,5045954251.4
Galectin-114,86663,68248,9861.3
Nucleoside diphosphate kinase17,2083,9362,2251.8
Peptidyl-prolyl cis-trans isomerase17,97167,24745,1051.5
Rho GDP-dissociation inhibitor 123,40712,0538,5761.4
Myosin light polypeptide 616,9612,9322,4141.2
Results of the analysis of ncMSC and hcMSC (mass spectrometry) An analysis of the histological data obtained in control animals revealed signs of acute injury to liver tissue and pronounced centrilobular liver congestion (Figure 3A–B). The blood-congested areas occupied from 1/2 to 2/3 of the lobular areas, sometimes merging with each other. The central parts of the lobules were characterized by discomplexation of the hepatic cords and destruction of some hepatocytes accompanied by karyorrhexis. Homogenization and total distinct small-droplet fatty degeneration, with a tendency to a fat droplet increase, was observed in the cytoplasm of intact hepatic cells of these lobular parts. Hepatocytes at the periphery of lobules were in the state of granular protein dystrophy and small-droplet obesity. There was a coarse and granular distribution of chromatin in the nuclei of these cells. Single hepatocytes with a large hyperchromic nucleus and binuclear cells were found among them. Dilation and congestion of the hepatic veins were observed in some specimens.
Figure 3

Histology of mouse liver after acetaminophen injection (270 mg/kg), stained with hematoxylin and eosin. Control 4 hrs after the injection (A) x160; (B) x400; 4 hrs after acetaminophen injection (270 mg/kg) and simultaneous treatment with ncMSC (10–30 kDa) protein compositions (C) x200; (D) x400; 4 hrs after acetaminophen injection (270 mg/kg) and simultaneous treatment with hcMSC (10–30 kDa) protein compositions (E) x200; (F) x400.Abbreviations: hc-MSC, MSCs cultured under hypoxic (10% O2 hc-MSC) condition; nc-MSC MSCs cultured under normal (21% O2 nc-MSC) condition.

Histology of mouse liver after acetaminophen injection (270 mg/kg), stained with hematoxylin and eosin. Control 4 hrs after the injection (A) x160; (B) x400; 4 hrs after acetaminophen injection (270 mg/kg) and simultaneous treatment with ncMSC (10–30 kDa) protein compositions (C) x200; (D) x400; 4 hrs after acetaminophen injection (270 mg/kg) and simultaneous treatment with hcMSC (10–30 kDa) protein compositions (E) x200; (F) x400.Abbreviations: hc-MSC, MSCs cultured under hypoxic (10% O2 hc-MSC) condition; nc-MSC MSCs cultured under normal (21% O2 nc-MSC) condition. An analysis of the histological data obtained for animals injected with the 10–30 kDa ncMSC fraction compared to those in the control group revealed that the cord structure of hepatic lobules was preserved (Figure 3C–D). Congestion was less pronounced. The sinusoids at the periphery of lobules were not enlarged. The cell membranes of hepatocytes in this area retained clear contours. The hepatocyte cytoplasm was characterized by pulverized obesity. A coarse chromatin distribution was detected in the cell nuclei. Single nuclei had a vesicular structure. There were rare binuclear hepatocytes. The morphological picture of the liver in animals injected with the hcMSC fraction was characterized by the most favorable appearance: congestion of the lobules was usually not observed (Figure 3E–F). The cord structure of lobules was preserved. The cytoplasm of centrilobular hepatocytes presented with signs of swelling as well as granular protein and dusty fatty degeneration. The outer cell membranes had distinct contours. The nuclei of hepatocytes were characterized mainly by a fine chromatin distribution. At the periphery of lobules, there were an increased number of cells with a uniform chromatin distribution and large hyperchromic nuclei. There were a greater number of binuclear cells. The morphometric analysis revealed that there was pronounced injury to liver tissue 4 hrs after APAP introduction (Table 2). In this case, introduction of the 10–30 kDa hcMSC fraction exerted the maximum protective effect, significantly differing from the control group and the 10–30 kDa ncMSC-treated group.
Table 2

The morphometric analysis revealed that there was pronounced injury to liver tissue 4 hrs after acetaminophen introduction

ParameterControlncMSC10–30 kDahcMSC10–30 kDa
Score (mean)4.453.9253.075
Standard error0.080.080.04
Standard deviation0.500.530.27
Variance0.250.280.07
Number of measurements404040

Abbreviations: hc-MSC, MSCs cultured under hypoxic (10% O2 hc-MSC) condition; nc-MSC MSCs cultured under normal (21% O2 nc-MSC) condition.

The morphometric analysis revealed that there was pronounced injury to liver tissue 4 hrs after acetaminophen introduction Abbreviations: hc-MSC, MSCs cultured under hypoxic (10% O2 hc-MSC) condition; nc-MSC MSCs cultured under normal (21% O2 nc-MSC) condition.

Discussion

Treatment of APAP-induced ALF requires serious medical measures and, in some cases, liver transplantation. The use of NAC as an antidote is associated with a number of side effects.4 In addition, the therapeutic window for NAC administration is rather narrow, which, as has been shown, reduces its efficacy in APAP-treated mice.5 A number of studies have demonstrated that MSCs can be an effective method for the prevention and treatment of APAP-induced ALF. However, cell transplantation has several limitations. The use of autologous MSCs in the acute period is actually impossible because a sufficient dose of cells should be introduced within the first hours after an event to achieve a positive clinical effect. In this case, it is necessary to emphasize the apparent dose dependence of the clinical effect on the amount of transplanted cellular material.14 The use of a high dose of allogeneic cells may lead to severe complications and immune dysfunction.15,16 One of the possible ways to solve this problem may be the use of paracrine factors produced by stem cells. The effectiveness of their use was demonstrated in our previous work.9 However, we believe that the use of the total fraction is not reasonable. Our findings demonstrated that the 10–30 kDa fraction had a protective effect via inhibition of APAP-induced ALF. At the same time, the medium fraction obtained under low oxygen content conditions was maximally effective. One of the possible causes for this effect may be a quantitative difference in the peptide composition, which was detected by LC-MS. As can be seen from Table 1, concentrations of 10 proteins increased from 1.2- to 13.1-fold. The concentration of three proteins increased to a detectable level. According to the literature data, three of the presented proteins (galectin-1, Trx, SOD) can reduce the degree of injury during the development of APAP-induced ALF. Galectin-1 is a protein secreted by stem cells into culture medium; it inhibits the inflammatory response by suppressing proliferation of T lymphocytes.17,18 A study by Ryu et al demonstrated that tonsil-derived MSCs were able to inhibit the development of ConA-induced hepatitis via the production of galectin-1. The authors attributed this effect to blockade of CD4+ T lymphocyte activation by galectin-1.14 Trx is a protein that regulates the production of reactive oxygen species and is produced in response to oxidative stress.19,20 This protein exerts an anti-inflammatory effect via inhibition of neutrophil chemotaxis.21 Okuyama et al reported that an increase in Trx expression prevented the development of acute hepatitis caused by thioacetamide or LPS.22 Taneka et al demonstrated that albumin-conjugated Trx effectively reduced the degree of liver injury caused by APAP.23 It should be noted that a decrease in the oxygen level during MSC cultivation leads to a sharp (2.6-fold) increase in MIF production. According to the literature, this pro-inflammatory factor increases the degree of injury to liver tissue.24 However, on the other hand, MIF was shown to increase survival of MSCs in hypoxic conditions protecting cells from hypoxia-induced apoptosis and reducing the level of oxidative stress25 Perhaps, this mechanism may occur in hepatocytes exposed to APAP.
  24 in total

1.  Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.

Authors:  Jae W Lee; Xiaohui Fang; Naveen Gupta; Vladimir Serikov; Michael A Matthay
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

Review 2.  Redox regulation of lung inflammation by thioredoxin.

Authors:  Takayuki Nakamura; Hajime Nakamura; Tomoaki Hoshino; Shugo Ueda; Hiromi Wada; Junji Yodoi
Journal:  Antioxid Redox Signal       Date:  2005 Jan-Feb       Impact factor: 8.401

3.  Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis.

Authors:  H Nakamura; L A Herzenberg; J Bai; S Araya; N Kondo; Y Nishinaka; L A Herzenberg; J Yodoi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

4.  Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.

Authors:  M Sundin; C Orvell; I Rasmusson; B Sundberg; O Ringdén; K Le Blanc
Journal:  Bone Marrow Transplant       Date:  2006-06       Impact factor: 5.483

5.  Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice.

Authors:  Hiroaki Okuyama; Hajime Nakamura; Yasuyuki Shimahara; Shinichi Araya; Norifumi Kawada; Yoshio Yamaoka; Junji Yodoi
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

Review 6.  Adverse reactions associated with acetylcysteine.

Authors:  E A Sandilands; D N Bateman
Journal:  Clin Toxicol (Phila)       Date:  2009-02       Impact factor: 4.467

7.  Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell.

Authors:  Yves Lepelletier; Séverine Lecourt; Amédée Renand; Bertrand Arnulf; Valérie Vanneaux; Jean-Paul Fermand; Philippe Menasché; Thomas Domet; Jean-Pierre Marolleau; Olivier Hermine; Jérôme Larghero
Journal:  Stem Cells Dev       Date:  2010-07       Impact factor: 3.272

8.  Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness.

Authors:  Mohammed Bourdi; Timothy P Reilly; Abdel G Elkahloun; John W George; Lance R Pohl
Journal:  Biochem Biophys Res Commun       Date:  2002-06-07       Impact factor: 3.575

9.  Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine.

Authors:  Chieko Saito; Claudia Zwingmann; Hartmut Jaeschke
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

10.  Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.

Authors:  Ninette Amariglio; Abraham Hirshberg; Bernd W Scheithauer; Yoram Cohen; Ron Loewenthal; Luba Trakhtenbrot; Nurit Paz; Maya Koren-Michowitz; Dalia Waldman; Leonor Leider-Trejo; Amos Toren; Shlomi Constantini; Gideon Rechavi
Journal:  PLoS Med       Date:  2009-02-17       Impact factor: 11.069

View more
  6 in total

1.  Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration.

Authors:  Meadhbh Á Brennan; Pierre Layrolle; David J Mooney
Journal:  Adv Funct Mater       Date:  2020-03-11       Impact factor: 18.808

Review 2.  Extracellular vesicles: Roles and applications in drug-induced liver injury.

Authors:  David S Umbaugh; Hartmut Jaeschke
Journal:  Adv Clin Chem       Date:  2020-10-01       Impact factor: 5.394

Review 3.  Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury.

Authors:  Chenxia Hu; Lingfei Zhao; Lingjian Zhang; Qiongling Bao; Lanjuan Li
Journal:  Stem Cell Res Ther       Date:  2020-09-03       Impact factor: 6.832

Review 4.  Mesenchymal stromal cells (MSCs) and their exosome in acute liver failure (ALF): a comprehensive review.

Authors:  Samin Shokravi; Vitaliy Borisov; Burhan Abdullah Zaman; Firoozeh Niazvand; Raheleh Hazrati; Meysam Mohammadi Khah; Lakshmi Thangavelu; Sima Marzban; Armin Sohrabi; Amir Zamani
Journal:  Stem Cell Res Ther       Date:  2022-05-08       Impact factor: 8.079

Review 5.  Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses.

Authors:  Luis A Costa; Noemi Eiro; María Fraile; Luis O Gonzalez; Jorge Saá; Pablo Garcia-Portabella; Belén Vega; José Schneider; Francisco J Vizoso
Journal:  Cell Mol Life Sci       Date:  2020-07-22       Impact factor: 9.261

6.  Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl4-Induced Liver Fibrosis.

Authors:  Gamal Shiha; Ahmed Nabil; Ahmed Lotfy; Reham Soliman; Ayman A Hassan; Islam S Ali; Doaa F Gad; Faten Zahran
Journal:  Stem Cells Int       Date:  2020-02-03       Impact factor: 5.443

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.